Why COVID-19 Vaccine Packaging And Delivery Devices has been a bust

Posted by Mrudula Anil Karmarkar on January 9th, 2022

The global COVID-19 vaccine packaging and delivery devices market size is anticipated to reach USD 3.6 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.4% from 2022 to 2028. High demand for immunization for the ongoing pandemic and manufacturer\'s initiatives to expand their production capacities are the factors expected to boost the demand for packaging materials.

The hurtling vaccine inoculation rate and growing public trust in COVID-19 vaccines are anticipated to fuel the growth of the market. According to the global attitude towards the COVID-19 vaccine survey, the share of people going for immunization has increased significantly in 2021. The increasing public willingness to get vaccinated early is expected to drive the manufacturing and distribution process, propelling market growth over the forecast period.

The increasing funding and investments in R&D activities specific to the development of an innovative vaccine, packaging material, and delivery devices are anticipated to fuel the growth of the market during the forecast period. For instance, the federal government of the U.S. invested USD 143 million to develop plastic alternatives to conventional glass vials for the storage of biological liquids.

Scientists around the world are investigating the scope of needles free delivery that would eliminate the need for vials and syringes hindering the market growth in the extended run. For instance, scientists at the University of Texas developed a film-based peelable inexpensive COVID-19 vaccine delivery device. On the other side, Bharath Biotech develops an innovative nasal vaccine to battle COVID-19.

COVID-19 vaccines are packed in multidose glass vials like many other pharmaceutical liquid formulations. The distribution will require suitable packaging to avoid wastage. The speeding rollouts, expanding production capacity, and a significant number of vaccines in the late stages of clinical approvals are the factors expected to primarily contribute to the growth of the market for COVID-19 vaccine packaging and delivery devices. Till April 2021, more than 50.0% of the U.S. population aged 65 years has been fully vaccinated.

To Request Sample Copy of this report, click the link:

https://www.grandviewresearch.com/industry-analysis/covid-19-vaccine-packaging-delivery-device-market/request/rs1

COVID-19 Vaccine Packaging And Delivery Devices Market Report Highlights

• Based on the product, syringes held the largest proportion of the market share in 2021
• Prefilled syringes are expected to grow at the fastest rate owing to their advantages such as usage simplicity, low cost, and ease of distribution
• The plastic vials segment is anticipated to register a lucrative CAGR during the forecast period
• The glass vials segment accounted for a major proportion of the market share in 2021
• The empty syringes segment is expected to grow at a healthy rate due to the speeding COVID-19 vaccination rates globally
• North America holds the largest share in this market. The U.S. is one of the major suppliers globally
• In Asia Pacific, the market is expected to grow at the fastest rate over the forecast period due to building people trust in the approved vaccines and the public readiness to get vaccinated

The key companies are observed to enter into long agreements with national governments and vaccine developers. For instance, in July 2020, BD entered into an agreement with the U.S. government to supply an additional 140 million injection devices, bringing the order total to 190 Million from BD itself. At the same time, the Canadian government bumped in its 75 Million injection device order. The major market players are observed to adopt strategies such as market expansion, product differentiation, mergers, collaboration, and capacity expansion to be order winners in the highly competitive environment. For instance, in December 2020, Schott Kaisha, an Indian-based subsidiary of Schott AG, invested around USD 17 Million to expand its vial manufacturing capacity by 300 million to prepare for the potential surge in demand for vials and syringes. Some of the prominent players in the COVID-19 vaccine packaging and delivery devices market include.

• BD
• B. Braun Melsungen AG
• Hindustan Syringes & Medical Devices Ltd.
• Terumo
• NIPRO Medical Corporation
• SCHOTT AG
• Gerresheimer AG
• Cardinal Health